Tell FDA: Revoke Approval of Unproven Alzheimer's Drug Aducanumab

The Food and Drug Administration recently approved a new medication for the treatment of Alzheimer’s disease.

But — as Public Citizen has noted — there is nowhere near enough evidence that the drug, aducanumab, is effective. In fact, geriatric experts and the FDA’s own independent advisory committee strongly urged the agency NOT to approve the medication.

Here’s what Dr. Michael Carome — director of Public Citizen’s Health Research Group — said in a statement to the national media:

“The FDA’s decision shows a stunning disregard for science and eviscerates the agency’s standards for approving new drugs. Because of this reckless action, the agency’s credibility has been irreparably damaged.”

Tell the FDA

Aducanumab has not been shown to be effective and you know it. What’s more, Biogen is planning to charge such an absurd amount that it could overwhelm Medicare. Meanwhile, millions of Alzheimer’s patients and their families will be given false hope. And the development of other treatments may be delayed or shelved altogether. Revoke your approval of aducanumab immediately or risk permanent damage to the FDA’s credibility in the eyes of the American people.